Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTPON.L Regulatory News (TPON)

  • There is currently no data for TPON

Directorate Change

8 Jun 2023 07:00

RNS Number : 0140C
Triple Point VCT 2011 PLC
08 June 2023
 

8 June 2023

 

Triple Point VCT 2011 plc

(the "Company")

DIRECTORATE CHANGES

 

The Board of Directors of Triple Point VCT 2011 plc announces that Jamie Brooke has been appointed to the Board as an Independent Non-Executive Director and member of the Audit Committee with immediate effect. Following an orderly succession period, Chad Murrin, a Non-Executive Director of the Company, will not stand for re-election at the Company's AGM to be held on 19 July 2023 and will step down following the conclusion of the AGM.

 

Jamie read mathematics at Oxford University, and qualified as an Accountant with Deloitte. Jamie has gained over 25 years investment experience throughout his career. He previously worked at 3i and Quester in the venture and leveraged buyout divisions, and was formerly lead fund manager for the Hanover Catalyst Fund. Prior to which he was at Lombard Odier where as a fund manager he specialised in strategic UK small cap equity investing, having moved with the Volantis team from Henderson Global, and before that, Gartmore. Jamie has held directorships on over 20 boards, and is currently on the Board of Kelso Group Holdings plc, Flowtech Fluidpower plc and Chair of the Audit Committee of Chapel Down Group plc, listed on the Aquis Stock Exchange, and Oryx International Growth Fund.

 

No further information is required to be disclosed pursuant to Listing Rule 9.6.13R.

 

Jane Owen, Chair of the Company, said:

 

"On behalf of the Board I would like to thank Chad Murrin for his significant contribution over the years he has served on the Board. We would also like to thank him for his assistance through the succession period, and he will retire from the Company with our very best wishes for the future.

 

We are delighted to welcome Jamie to the Company. His extensive Venture and listed company experience will be hugely valuable to the Board as the Company continues to grow with its sole focus on the Venture Fund."

 

 

FOR FURTHER INFORMATION ON THE COMPANY, PLEASE CONTACT

 Triple Point Investment Management LLP (Investment Manager)

Tel: 020 7201 8989

 Ian McLennan

 Belinda Thomas

 

The Company's LEI is 213800AOOAQA5XQDEA89

 

Further information on the Company can be found on its website https://www.triplepoint.co.uk/current-vcts/triple-point-vct-2011-plc/s2539/

NOTES:

The Company is a Venture Capital Trust incorporated in July 2010 and was established to fund small and medium sized enterprises. The Investment Manager is Triple Point Investment Management LLP.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUBAQUPWGQM
Date   Source Headline
8th Jun 202110:24 amRNSIssue of Supplementary Prospectus
1st Jun 20214:06 pmRNSVenture Share Class Net Asset Value
27th May 20217:05 amRNSDividend Declaration
27th May 20217:00 amRNSRESULTS FOR THE YEAR ENDED 28 FEBRUARY 2021
27th Apr 20211:59 pmRNSB Share Class Net Asset Value
1st Apr 20214:21 pmRNSIssue of Equity and Total Voting Rights
1st Apr 202110:20 amRNSTotal Voting Rights
30th Mar 20214:00 pmRNSIssue of Equity and Total Voting Rights
3rd Mar 20214:03 pmRNSIssue of Equity and Total Voting Rights
2nd Mar 20215:34 pmRNSVenture Share Class NAV and Allotment Dates
18th Jan 20214:02 pmRNSNet Asset Value(s)
4th Jan 20212:29 pmRNSTotal Voting Rights
21st Dec 20204:29 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20202:08 pmRNSVenture Share Class Net Asset Value
3rd Nov 20207:00 amRNSInvestment Update
19th Oct 20202:27 pmRNSResult of General Meeting
12th Oct 20201:55 pmRNSResults for the six months ended 31 August 2020
23rd Sep 20207:00 amRNSInvestment Update
14th Sep 20202:00 pmRNSPublication of Prospectus and Circular
6th Aug 20201:00 pmRNSIntention to Launch an Offer for Subscription
3rd Aug 202011:24 amRNSTotal Voting Rights
31st Jul 20205:00 pmRNSIssue of Equity and Total Voting Rights
15th Jul 20204:00 pmRNSIssue of Equity and Total Voting Rights
9th Jul 20203:06 pmRNSNet Asset Value(s)
9th Jul 20202:00 pmRNSResult of Annual General Meeting
1st Jul 20207:00 amRNSTotal Voting Rights
26th Jun 20207:00 amRNS2020 Annual General Meeting Update
16th Jun 20202:18 pmRNSOffer Update
16th Jun 20201:08 pmRNSInvestment Update
5th Jun 20204:20 pmRNSAnnual Financial Report and Notice of AGM
1st Jun 202012:38 pmRNSIssue of Equity and Total Voting Rights
21st May 20205:18 pmRNSDividend Declaration
21st May 20204:54 pmRNSRESULTS FOR THE YEAR ENDED 29 FEBRUARY 2020
1st May 20207:00 amRNSCompany Secretary Change
1st May 20207:00 amRNSTotal Voting Rights
30th Apr 20204:24 pmRNSAmendment to the Investment Management Agreement
21st Apr 20207:00 amRNSCoronavirus (COVID-19) Update
3rd Apr 20204:00 pmRNSIssue of Equity and Total Voting Rights
1st Apr 20203:00 pmRNSIssue of Equity and Total Voting Rights
1st Apr 20207:00 amRNSTotal Voting Rights
30th Mar 202010:00 amRNSNet Asset Value(s)
10th Mar 20204:40 pmRNSIssue of Equity and Total Voting Rights
27th Feb 202010:27 amRNSInvestment Update
18th Feb 202011:16 amRNSTransaction in Own Shares
6th Feb 20201:00 pmRNSDividend Declaration
16th Jan 20203:08 pmRNSNet Asset Value(s)
13th Dec 20193:51 pmRNSInvestment Update
13th Dec 201910:50 amRNSInvestment Update
4th Dec 20195:53 pmRNSInvestment Update
2nd Dec 20194:38 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.